ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

Tower Research Capital LLC (TRC)'s Holding History (CIK: 0001533421)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,304 Value ($000) $35 Avg Close $19.92 Range $15.14 - $24.64
Q3 2025
Shares 1,576 Value ($000) $32 Avg Close $20.16 Range $17.43 - $24.38
Q2 2025
Shares 5,286 Value ($000) $106 Avg Close $18.93 Range $13.30 - $24.11
Q1 2025
Shares 1,796 Value ($000) $35 Avg Close $21.52 Range $18.67 - $25.37
Q4 2024
Shares 1,598 Value ($000) $36 Avg Close $25.92 Range $21.43 - $30.03
Q3 2024
Shares 484 Value ($000) $12 Avg Close $23.16 Range $20.63 - $27.67
Q2 2024
Shares 3,243 Value ($000) $76 Avg Close $21.05 Range $15.96 - $26.00
Q1 2024
Shares 506 Value ($000) $9 Avg Close $15.34 Range $10.90 - $19.50
Q4 2023
Shares 5,485 Value ($000) $76 Avg Close $12.23 Range $9.80 - $15.41
Q3 2023
Shares 6,755 Value ($000) $92 Avg Close $16.84 Range $12.38 - $20.77
Q2 2023
Shares 1,382 Value ($000) $28 Avg Close $20.21 Range $17.15 - $23.98
Q1 2023
Shares 1,657 Value ($000) $0 Avg Close $20.34 Range $14.56 - $25.34